Category Regulatory

IMVARIA Presents Multi-Site Clinical Data on FDA-Approved AI Tool for Pulmonary Fibrosis at ATS 2025

IMVARIA Showcases Real-World Success of FDA-Authorized AI Tool Fibresolve for Lung Disease Diagnosis at ATS 2025 IMVARIA Inc., a trailblazing health tech company specializing in AI-driven digital biomarker solutions, is making waves in the medical community with its groundbreaking diagnostic…

Read MoreIMVARIA Presents Multi-Site Clinical Data on FDA-Approved AI Tool for Pulmonary Fibrosis at ATS 2025

Northern Trust Awarded Best Private Bank in the U.S. for Digital Wealth Planning and Customer Experience

Northern Trust Wins Top Honors as Best Private Bank in the U.S. for Digital Wealth Planning and Customer Experience Northern Trust, a global leader in wealth management services, has been named “Best Private Bank in the U.S. for Digital Wealth…

Read MoreNorthern Trust Awarded Best Private Bank in the U.S. for Digital Wealth Planning and Customer Experience

CrowdStrike Recognized as a Leader and Fast Mover in the 2025 GigaOm Radar Report for XDR Solutions

CrowdStrike Named a Leader and Fast Mover in the 2025 GigaOm Radar Report for XDR Solutions In a significant recognition of its innovation and leadership in cybersecurity, CrowdStrike (NASDAQ: CRWD) has been named a Leader and Fast Mover in the…

Read MoreCrowdStrike Recognized as a Leader and Fast Mover in the 2025 GigaOm Radar Report for XDR Solutions

Instem Reinforces Dedication to Comprehensive Preclinical Platform Amid Evolving Regulatory Landscape

Instem Reinforces Commitment to End-to-End Preclinical Solutions Amid Evolving Regulatory Landscape In response to the FDA’s recent announcement expanding flexibility in preclinical submission evidence, Instem, a global leader in life sciences technology, is reaffirming its position as the industry’s trusted…

Read MoreInstem Reinforces Dedication to Comprehensive Preclinical Platform Amid Evolving Regulatory Landscape

Quantum Knight Secures FDA Authorization, Pioneering a New Era in Cryptographic Security

Quantum Knight Achieves FDA Authorization for CLEAR™, Setting a New Standard in Quantum-Ready Cryptographic Security In a landmark achievement for cryptographic security, Quantum Knight, a leader in quantum-secure encryption and cybersecurity innovation, has received FDA Authority to Operate (ATO) for…

Read MoreQuantum Knight Secures FDA Authorization, Pioneering a New Era in Cryptographic Security

Ameresco Honors Double Victory for Innovative Projects in 2025 Environment + Energy Leader Awards

Ameresco Secures Double Win in 2025 Environment+Energy Leader Awards for Groundbreaking Energy Projects In a remarkable achievement, Ameresco, Inc. (NYSE: AMRC), a leading energy solutions provider, has been recognized with two prestigious awards in the 2025 Environment+Energy Leader (E+E) Product…

Read MoreAmeresco Honors Double Victory for Innovative Projects in 2025 Environment + Energy Leader Awards

Hypori Achieves FedRAMP High Authorization: Enhancing Data Security for Government and Defense Contractors

Hypori Achieves FedRAMP High Authorization: Elevating Data Security for Government and Defense Contractors In today’s increasingly digital world, data security is paramount—especially for government agencies, defense contractors, and enterprises handling sensitive information. Hypori, a leading cybersecurity SaaS provider specializing in…

Read MoreHypori Achieves FedRAMP High Authorization: Enhancing Data Security for Government and Defense Contractors

Accenture Siemens Group Launches to Transform Engineering and Manufacturing for Clients

Accenture Siemens Business Group Launches to Revolutionize Engineering and Manufacturing with AI-Powered Solutions In a groundbreaking move set to redefine the future of engineering and manufacturing, Siemens and Accenture (NYSE: ACN) have announced the formation of the Accenture Siemens Business…

Read MoreAccenture Siemens Group Launches to Transform Engineering and Manufacturing for Clients

Poxel Secures New Patent in Japan for Imeglimin’s Use in Type 2 Diabetes Patients with Renal Impairment

Poxel Secures New Patent in Japan for Imeglimin’s Use in Type 2 Diabetes Patients with Renal Impairment POXEL SA (Euronext: POXEL – FR0012432516), a clinical-stage biopharmaceutical company specializing in innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic…

Read MorePoxel Secures New Patent in Japan for Imeglimin’s Use in Type 2 Diabetes Patients with Renal Impairment

Altasciences Wins 2025 CDMO Leadership Award for Small Molecule Dosage Form Excellence

Altasciences Wins 2025 CDMO Leadership Award for Small Molecule Dosage Form Excellence in North America Altasciences, a renowned leader in contract research and development, is proud to announce its recognition as the recipient of the 2025 CDMO Leadership Award in…

Read MoreAltasciences Wins 2025 CDMO Leadership Award for Small Molecule Dosage Form Excellence